US Stock MarketDetailed Quotes

ENTO Entero Therapeutics

Watchlist
  • 0.474
  • +0.019+4.18%
Close Nov 29 13:00 ET
  • 0.477
  • +0.003+0.68%
Post 17:01 ET
2.25MMarket Cap0.04P/E (TTM)

Entero Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-44.87%1.89M
-18.07%3.43M
127.10%9.23M
24.39%15.77M
79.57%4.09M
178.21%3.43M
-22.65%4.18M
-56.70%4.06M
-77.64%12.68M
-74.14%2.28M
Selling and administrative expenses
-30.41%1.69M
13.36%3.21M
220.64%8.66M
-10.42%10.74M
27.94%2.79M
-16.61%2.42M
13.19%2.83M
-38.70%2.7M
-34.80%11.99M
-28.28%2.18M
-General and administrative expense
-30.41%1.69M
13.36%3.21M
220.64%8.66M
-10.42%10.74M
27.94%2.79M
-16.61%2.42M
13.19%2.83M
-38.70%2.7M
-34.80%11.99M
-28.28%2.18M
Research and development costs
-79.53%207K
-83.77%219.59K
-58.44%565.96K
628.13%5.03M
1,183.99%1.31M
113.86%1.01M
-53.45%1.35M
-72.64%1.36M
-98.20%691.26K
-98.24%101.82K
Operating profit
44.87%-1.89M
18.07%-3.43M
-127.10%-9.23M
-24.39%-15.77M
-79.57%-4.09M
-178.21%-3.43M
22.65%-4.18M
56.70%-4.06M
77.64%-12.68M
74.14%-2.28M
Net non-operating interest income expense
122.43%229
104.38%218
-827.38%-65.97K
-167.04%-19.93K
-352.82%-6.82K
-156.69%-1.02K
-116.97%-4.97K
-30.15%-7.11K
25.82%-7.46K
-23.32%-1.51K
Non-operating interest income
----
--218
-87.83%228
-69.92%2.53K
----
----
----
1,247.48%1.87K
617.39%8.42K
299.49%4.69K
Non-operating interest expense
----
----
636.64%66.2K
41.46%22.46K
----
----
54.54%4.97K
60.34%8.99K
41.34%15.88K
158.58%6.19K
Total other finance cost
-122.43%-229
----
----
----
----
--1.02K
----
----
----
----
Other net income (expense)
-2.87K
-65.66%-4.33K
41.38%-653
99.78%-4.22K
99.97%-495
-2.62K
99.53%-1.11K
-6.65%-1.94M
27.65%-1.7M
Special income (charges)
----
----
----
--0
----
----
----
----
27.24%-1.71M
----
-Gain on sale of business
----
----
----
--0
----
----
----
----
---1.71M
----
Other non- operating income (expenses)
---2.87K
-65.66%-4.33K
41.38%-653
98.19%-4.22K
-107.55%-495
----
---2.62K
99.53%-1.11K
-143.99%-232.74K
253.13%6.56K
Income before tax
44.81%-1.9M
18.12%-3.43M
-128.27%-9.29M
-7.97%-15.79M
-2.88%-4.1M
-178.20%-3.43M
22.54%-4.19M
57.72%-4.07M
75.01%-14.63M
64.32%-3.99M
Income tax
0
4.26M
-14.86M
0
0
0
Net income
24.84%-2.58M
-110.25%-8.81M
236.77%5.57M
-7.97%-15.79M
-2.88%-4.1M
-178.20%-3.43M
22.54%-4.19M
57.72%-4.07M
75.01%-14.63M
64.32%-3.99M
Net income continuous Operations
44.81%-1.9M
-83.46%-7.69M
236.77%5.57M
-7.97%-15.79M
-2.88%-4.1M
-178.20%-3.43M
22.54%-4.19M
57.72%-4.07M
75.01%-14.63M
64.32%-3.99M
Net income discontinuous operations
---685.72K
---1.12M
----
----
----
--0
--0
----
----
----
Minority interest income
Net income attributable to the parent company
24.84%-2.58M
-110.25%-8.81M
236.77%5.57M
-7.97%-15.79M
-2.88%-4.1M
-178.20%-3.43M
22.54%-4.19M
57.72%-4.07M
75.01%-14.63M
64.32%-3.99M
Preferred stock dividends
71.70%84.63K
-59.65%38.06K
-24.35%66.14K
4.05%308.13K
3,827.32%77.08K
-55.30%49.29K
-2.88%94.32K
-3.70%87.43K
-98.86%296.13K
-101.78%-2.07K
Other preferred stock dividends
0
47.3K
0
Net income attributable to common stockholders
23.48%-2.67M
-106.51%-8.85M
232.31%5.5M
-7.55%-16.1M
-4.87%-4.18M
-182.28%-3.48M
22.85%-4.28M
57.21%-4.16M
82.28%-14.97M
64.71%-3.98M
Basic earnings per share
93.59%-0.59
89.77%-3.86
108.56%3.12
88.52%-47.88
96.66%-2.6765
-102.49%-9.21
96.47%-37.73
98.68%-36.46
98.95%-416.94
-110.93%-80.0788
Diluted earnings per share
93.59%-0.59
89.77%-3.86
101.04%0.38
88.52%-47.88
96.66%-2.6765
-102.53%-9.21
96.47%-37.73
98.68%-36.46
98.95%-416.94
-110.93%-80.0788
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -44.87%1.89M-18.07%3.43M127.10%9.23M24.39%15.77M79.57%4.09M178.21%3.43M-22.65%4.18M-56.70%4.06M-77.64%12.68M-74.14%2.28M
Selling and administrative expenses -30.41%1.69M13.36%3.21M220.64%8.66M-10.42%10.74M27.94%2.79M-16.61%2.42M13.19%2.83M-38.70%2.7M-34.80%11.99M-28.28%2.18M
-General and administrative expense -30.41%1.69M13.36%3.21M220.64%8.66M-10.42%10.74M27.94%2.79M-16.61%2.42M13.19%2.83M-38.70%2.7M-34.80%11.99M-28.28%2.18M
Research and development costs -79.53%207K-83.77%219.59K-58.44%565.96K628.13%5.03M1,183.99%1.31M113.86%1.01M-53.45%1.35M-72.64%1.36M-98.20%691.26K-98.24%101.82K
Operating profit 44.87%-1.89M18.07%-3.43M-127.10%-9.23M-24.39%-15.77M-79.57%-4.09M-178.21%-3.43M22.65%-4.18M56.70%-4.06M77.64%-12.68M74.14%-2.28M
Net non-operating interest income expense 122.43%229104.38%218-827.38%-65.97K-167.04%-19.93K-352.82%-6.82K-156.69%-1.02K-116.97%-4.97K-30.15%-7.11K25.82%-7.46K-23.32%-1.51K
Non-operating interest income ------218-87.83%228-69.92%2.53K------------1,247.48%1.87K617.39%8.42K299.49%4.69K
Non-operating interest expense --------636.64%66.2K41.46%22.46K--------54.54%4.97K60.34%8.99K41.34%15.88K158.58%6.19K
Total other finance cost -122.43%-229------------------1.02K----------------
Other net income (expense) -2.87K-65.66%-4.33K41.38%-65399.78%-4.22K99.97%-495-2.62K99.53%-1.11K-6.65%-1.94M27.65%-1.7M
Special income (charges) --------------0----------------27.24%-1.71M----
-Gain on sale of business --------------0-------------------1.71M----
Other non- operating income (expenses) ---2.87K-65.66%-4.33K41.38%-65398.19%-4.22K-107.55%-495-------2.62K99.53%-1.11K-143.99%-232.74K253.13%6.56K
Income before tax 44.81%-1.9M18.12%-3.43M-128.27%-9.29M-7.97%-15.79M-2.88%-4.1M-178.20%-3.43M22.54%-4.19M57.72%-4.07M75.01%-14.63M64.32%-3.99M
Income tax 04.26M-14.86M000
Net income 24.84%-2.58M-110.25%-8.81M236.77%5.57M-7.97%-15.79M-2.88%-4.1M-178.20%-3.43M22.54%-4.19M57.72%-4.07M75.01%-14.63M64.32%-3.99M
Net income continuous Operations 44.81%-1.9M-83.46%-7.69M236.77%5.57M-7.97%-15.79M-2.88%-4.1M-178.20%-3.43M22.54%-4.19M57.72%-4.07M75.01%-14.63M64.32%-3.99M
Net income discontinuous operations ---685.72K---1.12M--------------0--0------------
Minority interest income
Net income attributable to the parent company 24.84%-2.58M-110.25%-8.81M236.77%5.57M-7.97%-15.79M-2.88%-4.1M-178.20%-3.43M22.54%-4.19M57.72%-4.07M75.01%-14.63M64.32%-3.99M
Preferred stock dividends 71.70%84.63K-59.65%38.06K-24.35%66.14K4.05%308.13K3,827.32%77.08K-55.30%49.29K-2.88%94.32K-3.70%87.43K-98.86%296.13K-101.78%-2.07K
Other preferred stock dividends 047.3K0
Net income attributable to common stockholders 23.48%-2.67M-106.51%-8.85M232.31%5.5M-7.55%-16.1M-4.87%-4.18M-182.28%-3.48M22.85%-4.28M57.21%-4.16M82.28%-14.97M64.71%-3.98M
Basic earnings per share 93.59%-0.5989.77%-3.86108.56%3.1288.52%-47.8896.66%-2.6765-102.49%-9.2196.47%-37.7398.68%-36.4698.95%-416.94-110.93%-80.0788
Diluted earnings per share 93.59%-0.5989.77%-3.86101.04%0.3888.52%-47.8896.66%-2.6765-102.53%-9.2196.47%-37.7398.68%-36.4698.95%-416.94-110.93%-80.0788
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data